Patent Assignment
Reel/Frame 009408/0282
Change of Name
Recorded: 1998-08-21
Pages: 3
Assignor
FUJI IMMUNOPHARMACEUTICALS CORPORATION
Executed: 1997-12-22
Assignee
LEXIGEN PHARMACEUTICALS CORPORATION
125 HARTWELL AVENUE, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Method for Inhibiting Retroviral Infection by Administering a Naphthalenesulfonic Acid Compound
Patent:
5,589,510 →
Application:
08/441,219 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 15, 1995
From: ONO, MITSUNORI; WADA, YUMIKO; WU, YAMING; KITAGUCHI, HIROSHI
To: FUJI IMMUNOPHARMACEUTICALS CORP.
Reel/Frame 007516/0658 →
Collateral Assignment of Patent as Security
Jan 30, 1998
From: FUJI IMMUNO PHARMACEUTICALS CORP.
To: FUJI PHOTO FILM FINANCE U.S.A. INC. AS COLLATERAL AGENT FOR ITSELF; BANK OF TOKYO TRUST COMPANY, THE
Reel/Frame 008967/0028 →
Release of Collateral Assignment of Patents of Security Agreement
Jan 19, 1999
From: FUJI PHOTO FILM FINANCE U.S.A., INC., AS COLLATERAL AGENT FOR ITSELF AND THE BANK OF TOKYO TRUST CO.
To: LEXIGEN PHARMACEUTICALS CORP. F/K/A FUJI IMMUNOPHARMACEUTICALS CORP.
Reel/Frame 009737/0840 →
Change of Name
May 12, 2003
From: LEXIGEN PHARMACEUTICALS CORP.
To: EMD LEXIGEN RESEARCH CENTER CORP.
Reel/Frame 014051/0152 →
Assignment of Assignor's Interest
Feb 15, 2007
From: FUJIFILM HOLDINGS CORPORATION (FORMERLY FUJI PHOTO FILM CO., LTD.)
To: FUJIFILM CORPORATION
Reel/Frame 018904/0001 →
Change of Name
May 20, 2008
From: EMD LEXIGEN RESEARCH CENTER CORP.
To: EMD SERONO RESEARCH CENTER, INC.
Reel/Frame 020963/0382 →